|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 114, Issue 7 1265-1271, Copyright © 2001 by Company of Biologists
JOURNAL ARTICLES |
G Milligan
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
A range of approaches have recently provided evidence that G-protein-coupled receptors can exist as oligomeric complexes. Both homo-oligomers, comprising multiple copies of the same gene product, and hetero-oligomers containing more than one receptor have been detected. In several, but not all, examples, the extent of oligomerisation is regulated by the presence of agonist ligands, and emerging evidence indicates that receptor hetero-oligomers can display distinct pharmacological characteristics. A chaperonin-like role for receptor oligomerisation in effective delivery of newly synthesised receptors to the cell surface is a developing concept, and recent studies have employed a series of energy-transfer techniques to explore the presence and regulation of receptor oligomerisation in living cells. However, the majority of studies have relied largely on co-immunoprecipitation techniques, and there is still little direct information on the fraction of receptors existing as oligomers in intact cells.
This article has been cited by other articles:
![]() |
D. S. Redka, L. F. Pisterzi, and J. W. Wells Binding of Orthosteric Ligands to the Allosteric Site of the M2 Muscarinic Cholinergic Receptor Mol. Pharmacol., September 1, 2008; 74(3): 834 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S.-H. Park and K. Palczewski Diversifying the repertoire of G protein-coupled receptors through oligomerization PNAS, June 21, 2005; 102(25): 8793 - 8794. [Full Text] [PDF] |
||||
![]() |
E. Kostenis, G. Milligan, A. Christopoulos, C. F. Sanchez-Ferrer, S. Heringer-Walther, P. M. Sexton, F. Gembardt, E. Kellett, L. Martini, P. Vanderheyden, et al. G-Protein-Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor Circulation, April 12, 2005; 111(14): 1806 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Cao, A. Brelot, and M. von Zastrow The Composition of the {beta}-2 Adrenergic Receptor Oligomer Affects Its Membrane Trafficking after Ligand-Induced Endocytosis Mol. Pharmacol., January 1, 2005; 67(1): 288 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mesnier and J.-L. Baneres Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1 J. Biol. Chem., November 26, 2004; 279(48): 49664 - 49670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bakker, G. Dees, J. J. Carrillo, R. G. Booth, J. F. Lopez-Gimenez, G. Milligan, P. G. Strange, and R. Leurs Domain Swapping in the Human Histamine H1 Receptor J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Suzuki, E. Moriyoshi, D. Tsuchiya, and H. Jingami Negative Cooperativity of Glutamate Binding in the Dimeric Metabotropic Glutamate Receptor Subtype 1 J. Biol. Chem., August 20, 2004; 279(34): 35526 - 35534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ramsay, I. C. Carr, J. Pediani, J. F. Lopez-Gimenez, R. Thurlow, M. Fidock, and G. Milligan High-Affinity Interactions between Human {alpha}1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the {alpha}1L-Adrenoceptor Mol. Pharmacol., August 1, 2004; 66(2): 228 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Breit, M. Lagace, and M. Bouvier Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties J. Biol. Chem., July 2, 2004; 279(27): 28756 - 28765. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi, B. Gangadharan, L. F. Brass, W. Ruf, and B. M. Mueller Protease-Activated Receptors (PAR1 and PAR2) Contribute to Tumor Cell Motility and Metastasis Mol. Cancer Res., July 1, 2004; 2(7): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pivonello, C. Matrone, M. Filippella, L. M. Cavallo, C. Di Somma, P. Cappabianca, A. Colao, L. Annunziato, and G. Lombardi Dopamine Receptor Expression and Function in Clinically Nonfunctioning Pituitary Tumors: Comparison with the Effectiveness of Cabergoline Treatment J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1674 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Breitwieser G Protein-Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling Circ. Res., January 9, 2004; 94(1): 17 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pfeiffer, S. Kirscht, R. Stumm, T. Koch, D. Wu, M. Laugsch, H. Schroder, V. Hollt, and S. Schulz Heterodimerization of Substance P and {micro}-Opioid Receptors Regulates Receptor Trafficking and Resensitization J. Biol. Chem., December 19, 2003; 278(51): 51630 - 51637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Carrillo, J. Pediani, and G. Milligan Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins J. Biol. Chem., October 24, 2003; 278(43): 42578 - 42587. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Carron, A. Pascal, A. Djiane, J.-C. Boucaut, D.-L. Shi, and M. Umbhauer Frizzled receptor dimerization is sufficient to activate the Wnt/{beta}-catenin pathway J. Cell Sci., June 15, 2003; 116(12): 2541 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chelli and M. Alizon Rescue of HIV-1 Receptor Function through Cooperation between Different Forms of the CCR5 Chemokine Receptor J. Biol. Chem., October 11, 2002; 277(42): 39388 - 39396. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Zhu, L. B. Cook, and P. M. Hinkle Dimerization and Phosphorylation of Thyrotropin-releasing Hormone Receptors Are Modulated by Agonist Stimulation J. Biol. Chem., July 26, 2002; 277(31): 28228 - 28237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Azhar, A. Nomoto, and E. Reaven Hormonal regulation of adrenal microvillar channel formation J. Lipid Res., June 1, 2002; 43(6): 861 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Patel, U. Kumar, D. C. Lamb, J. S. Eid, M. Rocheville, M. Grant, A. Rani, T. Hazlett, S. C. Patel, E. Gratton, et al. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells PNAS, March 5, 2002; 99(5): 3294 - 3299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chelli and M. Alizon Determinants of the trans-Dominant Negative Effect of Truncated Forms of the CCR5 Chemokine Receptor J. Biol. Chem., December 7, 2001; 276(50): 46975 - 46982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Bermak and Q.-Y. Zhou Accessory Proteins in the Biogenesis of G Protein-Coupled Receptors Mol. Interv., December 1, 2001; 1(5): 282 - 287. [Abstract] [Full Text] [PDF] |
||||